Carr Douglas 4

What Happened

• Douglas Carr, SVP Finance & Operations at Century Therapeutics (IPSC), was granted two awards on 2026-02-02: 110,000 restricted stock units (RSUs) and 225,000 derivative awards (stock options). Both grants show an acquisition price of $0.00 (i.e., no cash paid at grant).

Key Details

• Transaction date(s) and price(s): 2026-02-02; both awards granted at $0.00 per share.
• Award amounts: 110,000 RSUs; 225,000 option/derivative awards.
• Vesting (from filing footnotes):
  • RSUs: 25% vest on Feb 2, 2027; remaining 75% vest quarterly over the following three years; RSUs will be settled in shares at each vesting date. (F1)
  • Options: 25% vest on Feb 2, 2027; remaining 75% vest in 36 equal monthly installments thereafter, subject to continued service. (F2)
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: Report filed 2026-02-04 for a 2026-02-02 transaction — appears to be timely (Form 4s are generally due within two business days).

Context

• These are compensation grants (award/award-type transactions, code "A") rather than open-market purchases or sales, so they represent standard executive pay/retention incentives rather than an immediate buy/sell signal.
• RSUs will convert to actual shares only as they vest; the option awards permit future acquisition of shares according to the stated vesting schedule.